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ABSTRACT
Tissue engineering strategies aim at controlling the behavior of individual cells to stimulate tissue
formation. This control is achieved by mimicking signals that manage natural tissue development
or repair. Flow perfusion bioreactors that create culture environments with minimal diffusion con-
straints and provide cells with mechanical stimulation may closely resemble in vivo conditions for
bone formation. Therefore, these culturing systems, in conjunction with an appropriate scaffold and
cell type, may provide significant insight towards the development of in vitro tissue engineering mod-
els leading to improved strategies for the construction of bone tissue substitutes. The objective of
this study was to investigate the in vitro localization of several bone growth factors that are usually
associated with bone formation in vivo by culturing rat bone marrow stromal cells seeded onto
starch-based biodegradable fiber meshes in a flow perfusion bioreactor. The localization of several
bone-related growth factors–namely, transforming growth factor-!1, platelet-derived growth fac-
tor-A, fibroblast growth factor-2, vascular endothelial growth factor, and bone morphogenetic pro-
tein-2–was determined at two different time points in scaffolds cultured under perfusion conditions
at two different flow rates using an immunohistochemistry technique. The results show the pres-
ence of regions positively stained for all the growth factors considered, except platelet-derived growth
factor-A. Furthermore, the images obtained from the positively stained sections suggest an increase
in the immunohistochemically stained area at the higher flow rate and culture time. These obser-
vations demonstrate that flow perfusion augments the functionality of scaffold/cell constructs grown
in vitro as it combines both biological and mechanical factors to enhance cell differentiation and cell
organization within the construct. This study also shows that flow perfusion bioreactor culture of
marrow stromal cells, combined with the use of appropriate biodegradable fiber meshes, may con-
stitute a useful model to study bone formation and assess bone tissue engineering strategies in vitro.
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INTRODUCTION
BONE TISSUE ENGINEERING APPROACHES based on bio-degradable scaffolds seeded with cells and cultured in
vitro prior to implantation aim at creating in vitro envi-
ronments that mimic the biochemical and mechanical sig-
nals responsible for natural bone development and repair.
Therefore, in order to design successful strategies that en-
able the development of functional bone-like tissue sub-
stitutes, it is important to understand the mechanisms of
cell growth and differentiation involved in the formation
of bone tissue. Although techniques for studying bone
formation in vivo have been well developed for many
years, adequate in vitro models are not available. This is
due, in part, to the complexity of the bone formation pro-
cess. It is unlikely that osteoblastic cells in culture will
express and secrete all of the proteins necessary for the
formation of normally mineralized bone in vitro1 as it is
difficult to capture the complexities of the in vivo envi-
ronment.2 Nevertheless, the available data, most of which
are based on observations of normal fetal rat calvarial os-
teoblasts in prolonged culture, suggest that the process of
bone formation depends on the sequential expression and
interaction of a number of growth factors.1,3
A plethora of growth factors are involved in bone and
cartilage formation, and the repair of musculoskeletal 
tissues.4–8 Among the most widely studied bone growth
factors are transforming growth factor-!1 (TGF-!1),
platelet-derived growth factor (PDGF), bone morpho-
genetic proteins (BMP), fibroblast growth factors (FGF),
and insulin-like growth factors (IGF).4–9 However, other
growth factors have also been shown to have an effect
on bone cells,10 including members of the epidermal
growth factor family (EGF), transforming growth factor-
" (TGF-") and vascular endothelial growth factor
(VEGF).10 In fact, the total number of growth factors
known to affect proliferation, differentiation, and secre-
tory functions of bone-related cells increases continually
as a result of new techniques in protein biochemistry and
molecular biology.5 Therefore, assessment of the ex-
pression of bone growth factors may provide important
information on the functionality of bone-like tissue sub-
stitutes developed by in vitro bone tissue engineering sys-
tems. Additionally, it may provide clues for a better un-
derstanding of bone formation mechanisms.
In previous studies,11–13 we have used a flow perfu-
sion bioreactor as a culturing system for rat bone mar-
row stromal cells seeded onto starch-based biodegradable
scaffolds in order to evaluate the potential of this tissue
engineering approach for the generation of osteoinduc-
tive bone tissue replacement constructs. The results show
that biodegradable starch-based scaffolds, in conjunction
with a fluid flow bioreactor, enable the creation of cul-
ture environments with minimal diffusional constraints
and provide mechanical stimulation to marrow stromal
cells.11–13 This approach leads to enhancement of the dif-
ferentiation of the marrow stromal cells and development
of a bone-like extracellular matrix consisting of a car-
bonated apatite mineral similar to the major mineral com-
ponent of bone.11,12 The design of this flow perfusion
bioreactor enhances the distribution of nutrients because
it allows the transport of media through the intercon-
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nected pores of the scaffold. In addition, it offers a con-
venient way of providing mechanical stimulation to
cells by means of fluid shear stress, which is particu-
larly important in bone tissue engineering since bone
cells are known to be stimulated by mechanical sig-
nals.14,15 Furthermore, the magnitude of the shear
stresses experienced by the cells can be varied easily by
adjusting the flow rate of the media through the sys-
tem.16 Therefore, the characteristics of the flow perfu-
sion bioreactor, in conjunction with scaffolds having
suitable properties and porous structures, may facilitate
the in vitro development of tissue-like constructs for the
regeneration of bone tissue defects.
The present study investigates the localization of sev-
eral bone growth factors, usually associated with bone
formation in vivo, in tissue engineered constructs ob-
tained by in vitro culturing of rat bone marrow stromal
cells seeded onto a biodegradable polymer scaffold in a
flow perfusion bioreactor at different flow rates and cul-
ture periods. This work also describes a novel approach
in which an immunohistochemical technique was used to
assess the presence of several bone-related growth fac-
tors on samples obtained from the in vitro culture of cells
seeded onto a biodegradable scaffold using a bioreactor.
Specifically, this study was designed to answer the fol-
lowing questions: 1) Is it possible to use immunohisto-
chemical techniques to analyze the presence of bone
growth factors on samples cultured in vitro? 2) Are bone
growth factors, usually found in vivo, present in cell-
seeded scaffolds cultured in a flow perfusion bioreactor?
3) Is the in vitro tissue engineering approach described
suitable as a model for studies on bone formation?
MATERIALS AND METHODS
Scaffold preparation
The polymer scaffolds used in this study were based
on a blend of corn starch and poly(#-caprolactone)
(SPCL, 30/70 wt%) obtained by a fiber bonding pro-
cess consisting of spinning, cutting, and sintering fibers
with a diameter of !180 $m. The porosity and porous
structure of these scaffolds were characterized previ-
ously by microcomputed tomography ($CT) and scan-
ning electron microscopy (SEM), which showed that
the scaffolds exhibited a typical interconnected fiber
mesh structure with a porosity of approximately 75%.13
All samples were cut into discs with diameters of !8
mm and heights of 1.5–2 mm and were subsequently ster-
ilized using ethylene oxide. Prior to cell seeding, the scaf-
folds were immersed in 30 mL of serum-free medium 
in 50 mL tubes. Air was removed from the pores of the
scaffolds by generating vacuum with a 30 mL syringe
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equipped with an 18 gauge needle. The scaffolds were
left in serum-free medium overnight to allow for
swelling.
Isolation and expansion of rat bone 
marrow stromal cells
Rat bone marrow stromal cells (MSC) were obtained
from the femora and tibiae of male Wistar rats, with
weights ranging from 125–149 g (Harlan, Indianapolis,
IN). The isolation and culturing procedures of the rat
bone marrow stromal cells have been described in detail
elsewhere.13 Briefly, femora and tibiae were removed and
washed in medium with an antibiotic concentration 10
times higher than in the complete culture medium used
in the remaining experiments. The epiphyses were cut
off, and the diaphyses flushed with 5 mL of complete
medium (see below). The bone marrow obtained from all
the rats was pooled and plated into 75 cm2 flasks. The
cells were cultured at 37°C in a humidified atmosphere
with 5% CO2. The complete culture medium for the ex-
periment consisted of minimum essential medium ("-
MEM Eagle, Sigma, St. Louis, MO) supplemented with
10% fetal calf serum (FCS, Gemini, Woodlands, CA), 50
$g/mL ascorbic acid, 50 $g/mL gentamycin, 100 $g/mL
ampicillin, 0.3 $g/mL fungizone, 10 mM !-glyc-
erophosphate, and 10!8 M dexamethasone (Sigma). The
culture medium was refreshed after 24 h and thereafter
every 2 days until day 6.
Cell seeding
At near confluence, after 6 days of primary culture, the
adherent cells were enzymatically released using trypsin/
EDTA (0.25% w/v trypsin/0.02% EDTA, Sigma), con-
centrated by centrifugation at 400 g for 5 min and re-
suspended in complete medium. Subsequently, the scaf-
folds were inserted into flow system cassettes that were
placed in 6 well plates. Each scaffold was then seeded
with 300 $L of cell suspension containing 5 " 105 cells
and incubated for 2 h. Then, 10 mL of media was added
to each well, and the seeded scaffolds were incubated
overnight to allow further cell attachment. The following
day seeded scaffolds were placed into the flow perfusion
bioreactor and cultured in complete media for 10 and 16
days (6 scaffolds per culture time). Seeded scaffolds cul-
tured under static conditions (6 well plates) were used as
controls.
Cell culture
The flow perfusion bioreactor used in this study is de-
scribed in detail elsewhere.16 Briefly, this bioreactor con-
sists of 6 flow chambers, each containing a cassette in
which the scaffold is press-fitted. Gas-permeable silicon
tubing connects each flow chamber with a peristaltic
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pump and a media reservoir. Each chamber has an inde-
pendent pumping circuit, but all pumps draw media from
a common reservoir. For these experiments, two biore-
actor systems were used simultaneously at two different
flow rates, namely, 1 mL/min and 0.3 mL/min. The to-
tal volume of media continuously flowing in the system
was 210 mL, and the entire volume was changed every
3 days. The flow perfusion bioreactor was maintained in
an environment of 37°C with 5% CO2.
Immunohistochemical analysis
Sample processing. At the end of each culturing pe-
riod, the cell/mesh constructs were removed from the
bioreactors, rinsed with a phosphate buffer saline solu-
tion (PBS, 0.01 M, pH 7.4) and fixed in a 10% formalin
solution (Sigma). The constructs were then rinsed with
PBS, cut in half, embedded in optimal freezing temper-
ature compound (OCT, Tissue-Tek, Torrance, CA) and
frozen on dry ice. Serial sections (10 $m in thickness)
were prepared and stored at !80°C until staining. The
sections were marked according to their distance from
the surface of the scaffold in order to analyze differences
within a given scaffold. Sections obtained from all scaf-
folds were analyzed for the presence of each of the
growth factors being studied.
Primary antibodies. For this study, the following anti-
bodies were selected: anti-transforming growth factor-!1
(anti-TGF-!1, goat polyclonal antibody, sc-146-G), anti-
platelet-derived growth factor-A (anti-PDGF-A, mouse
monoclonal antibody, sc-9974), anti-fibroblast growth fac-
tor-2 (anti-FGF-2, goat polyclonal antibody, sc-79-G),
anti-vascular endothelial growth factor (anti-VEGF, mouse
monoclonal antibody, sc-7269), and anti-bone morpho-
genetic protein-2 (anti-BMP-2, goat polyclonal antibody,
sc-6895). All antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA) and used at a concentra-
tion of 2 $g/mL of 0.1 M PBS. The diluted antibody so-
lutions were used on the same day they were prepared. The
mouse monoclonal antibodies were used in conjunction
with an anti-mouse avidin-biotin complex ABC kit, and
the goat polyclonal antibodies were used in conjunction
with an anti-goat ABC kit (both Vectastain Elite ABC kit,
Vector Laboratories, Burlingame, CA).
Immunostaining procedure. The sections were im-
munostained using the avidin-biotin immunoperoxidase
staining technique, which is based on the ability of egg-
white glycoprotein avidin to nonimmunologically bind
four molecules of the vitamin biotin.17 This technique
uses three main reagents: 1) a primary antibody specific
for the antigen to be localized; 2) anti-mouse/anti-goat
polyclonal antibody (secondary), which is covalently
linked to a molecule of biotin; and 3) a complex of per-
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oxidase conjugated with biotin and avidin. The free sites
on the avidin molecule allow binding to the biotin pres-
ent on the second antibody. The peroxidase enzyme is
identified with an appropriate chromogen, allowing vi-
sualization of the original antigen.17
The experimental staining procedure was based on pre-
viously established protocols18 and can be briefly de-
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scribed as follows: the sections were first incubated in a
hydrogen peroxide solution to block against endogenous
peroxidase activity and then incubated with normal serum
(provided in the ABC kit referenced above) to block
against random secondary antibody binding. The sections
were then incubated with primary antibody for the anti-
gen of interest, followed by the avidin-biotin secondary
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TABLE 1. SEQUENCE AND LENGTH OF INCUBATION PERIODS INVOLVED IN IMMUNOHISTOCHEMICAL STAINING PROCEDURE
Step Reagent Incubation Rinses (2 ")
1 95% Ethanol 3 min Distilled water
2 H2O2/CH3OH 1 h Wash buffer*
3 Normal serum 1 h Wash buffer
4 Primary antibody 2 h Wash buffer
5 Secondary antibody 1 h Wash buffer
6 ABC reagent 1 h Distilled water
7 DAB reagent 10 min
8 Hematoxylin 8 min
9 Tap water 1 min (2 ")
10 Acid alcohol 3 min Distilled water
11 95% Ethanol 3 min (2 ")
12 100% Ethanol 3 min (2 ")
*Wash buffer: PBS with surfactant (OptiMax).
FIG. 1. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow 
perfusion for 10 and 16 days, at two different flow rates and stained with hematoxilin and eosin. (A) Construct cultured 
for 10 days at a flow rate of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/min. (C) Construct cultured
for 16 days at a flow rate of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1 mL/min. (Images available in
color in online version.)
antibody system and the developing reagent (3,3#-di-
aminobenzidin, DAB, Vector Laboratories). As a last
step, the sections were counterstained with hematoxylin
and mounted. The negative staining controls consisted of
sections incubated with 0.01 M PBS instead of the pri-
mary antibody. A group of samples received conventional
hematoxylin and eosin staining. The whole procedure
was performed at room temperature. Table 1 summarizes
the sequence and length of the incubation periods in-
volved in this staining procedure.
Image acquisition. All the stained sections were ob-
served with an Eclipse E600 light microscope (Nikon,
Melville, NY) equipped with a CCD camera (Sony DXC-
950P, New York, NY). For each stained section, three
digital images were taken, corresponding to the two ends
and center of the sample (magnification " 4).
RESULTS
Histological analysis of SPCL scaffold/cell constructs
stained for hematoxilin and eosin showed the presence
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of cells and matrix distributed throughout the interior of
the three-dimensional starch-based scaffolds and also the
formation of a thick surface layer of cells (Fig. 1). Fur-
thermore, these images suggest an increase in the num-
ber of cells and amount of matrix at the higher flow rate,
in agreement with previous studies15,19 that demonstrated
that flow perfusion culture enhances the osteoblastic dif-
ferentiation of marrow stromal cells (MSC) and improves
their distribution in the scaffolds in a dose-dependent
manner by improving nutrient delivery to the interior of
the scaffolds and stimulating the seeded cells by expos-
ing them to fluid shear forces. Additionally, an increase
in the number of cells and amount of matrix with in-
creasing culture time was observed, as expected. As a
comparison, Figure 2 shows images obtained from the
control sections, which were incubated with PBS instead
of the antibody. No positive staining was detected in these
sections.
Vascular endothelial growth factor (VEGF)
In Figure 3, typical light microscopy images show im-
munohistochemical staining of sample sections cultured
in the flow perfusion bioreactor for 10 and 16 days un-
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FIG. 2. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow 
perfusion for 10 and 16 days, at two different flow rates and incubated with PBS instead of a primary antibody (controls). 
(A) Construct cultured for 10 days at a flow rate of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/
min. (C) Construct cultured for 16 days at a flow rate of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1
mL/min. (Images available in color in online version.)
der two different flow rates. In addition to showing the
presence of stained areas in sections analyzed for VEGF,
these images suggest an increase in the immunohisto-
chemically stained area at the higher flow rate. This ef-
fect might be related to enhanced differentiation due to
increased mechanical stimulation of the cells. It has been
previously demonstrated that the increase of fluid flow
in this flow perfusion bioreactor leads to enhanced dif-
ferentiation and mineralization of marrow stromal cells
cultured in three-dimensional starch-based scaffolds.13 In
addition, there was an increase in growth factor expres-
sion after 16 days in culture relative to 10 days, which is
probably associated with increased cell and matrix con-
tent within the constructs.
Platelet-derived growth factor-A
Contrary to what was observed in the sections stained
for VEGF, the sections stained for PDGF-A looked sim-
ilar to the control samples, which were incubated with
PBS instead of the antibody, (Fig. 4). There was no pos-
itive staining for this growth factor, demonstrating that
PDGF-A is not expressed by MSCs cultured under the
described conditions. However, using the presently avail-
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able data, it is not possible to determine whether this
growth factor is present in this system at earlier or later
stages of culture.
Transforming growth factor-!1
Typical light microscopy images of sections obtained
from samples cultured in the flow perfusion bioreactor
for 10 and 16 days under two different flow rates and im-
munohistochemically stained for TGF-!1 are seen in Fig-
ure 5. In the sections obtained from samples cultured for
10 days at the lower flow rate, there are only some re-
gions that are positively stained. In contrast, for all re-
maining samples, there is widespread localization of this
growth factor. This indicates that expression of TGF-!1
can be related to a specific period of cell development,
which is enhanced by increasing the stimulation due to
higher flow rate used in the perfusion bioreactor.
Fibroblast growth factor
Images depicting sections obtained from scaffold/cell
constructs cultured under previously described conditions
and stained for FGF-2 are shown in Figure 6. They dem-
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FIG. 3. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow perfusion
for 10 and 16 days, at two different flow rates and immunostained for VEGF. (A) Construct cultured for 10 days at a flow rate
of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/min. (C) Construct cultured for 16 days at a flow rate
of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1 mL/min. (Images available in color in online version.)
onstrate the presence of several regions, corresponding
to cells and matrix formed within the construct, which
are positively stained for this growth factor. Once again,
a larger stained area is visible in the samples cultured un-
der the higher perfusion rate, demonstrating the capabil-
ity of influencing cell behavior by the selection of dif-
ferent levels of mechanical stimulation with the flow
perfusion bioreactor.
Bone morphogenetic protein-2
Figure 7 shows the light microscopy images of sec-
tions obtained from constructs cultured for 10 and 16 days
in the flow perfusion bioreactor, using flow rates of 0.3
and 1 mL/min and immunohistochemically stained for
BMP-2. In these images, it is possible to identify areas
positively stained for BMP-2, mostly localized in the cells
and their surrounding matrix. The sections stained for
BMP-2 that correspond to samples cultured at the higher
flow rate exhibit increased levels of expression of this
growth factor, demonstrated by the presence of a higher
number of spots per area positively stained. This was ob-
served in all the samples positively analyzed for the
growth factors previously described, indicating that it is
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possible to modulate cell development by tailoring the cul-
turing parameters. Specifically, this result suggests that
higher flow rates enhance the development of rat bone mar-
row cells, and therefore mechanical stimulation induced
by this culturing parameter to the cells can be adjusted to
lead to the development of tissue engineering constructs
in useful (i.e., shorter) culturing times and/or to obtain bone
tissue-like constructs with enhanced functionality.
DISCUSSION
The light microscopy images obtained from three dif-
ferent regions of each of the six samples studied per group
(culturing period–flow rate) that were immunohisto-
chemically analyzed consistently showed the presence of
regions positively stained for all the growth factors ex-
amined (namely, BMP-2, FGF-2, VEGF, and TGF-!1),
except for PDGF-A. These images suggest an increase in
the immunohistochemically stained area with increasing
flow rate, which was observed for all positively stained
sections, as well as a trend of enhanced growth factor ex-
pression over culturing time. The images taken from the
two ends of a sample revealed no differences in staining
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FIG. 4. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow perfusion
for 10 and 16 days, at two different flow rates and immunostained for PDGF-A. (A) Construct cultured for 10 days at a flow
rate of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/min. (C) Construct cultured for 16 days at a flow
rate of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1 mL/min. (Images available in color in online version.)
compared with that of the center (data not shown); the
image from the center of a sample is presented here. The
differences between sections of the same sample or sec-
tions of samples obtained using identical culture condi-
tions were also not significant.
The results provide evidence that growth factors can
be delivered into a scaffold via cotransplantation of cells
that can naturally produce them when cultured in stimu-
lating conditions and can accelerate the healing and/or
neotissue development upon implantation of the con-
struct. For instance, the presence of VEGF in these con-
structs, a polypeptide growth factor that is known to
specifically promote the proliferation of vascular endo-
thelial cells,10 may enhance vascular tissue formation
upon their implantation, increasing the viability of the
transplanted cells and tissue within the scaffold. In fact,
the induction of rapid vascular ingrowth has been a ma-
jor limitation in bone tissue engineering,20,21 particularly
when the aim is to restore a large tissue defect. This is
because when a tissue engineered construct is implanted
the transplanted cells, as well as the native host cells that
migrate into the scaffold, depend upon the transport of
nutrients and waste products between the cells and the
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host tissue for survival; as the transport in this first stage
is carried out exclusively by diffusion, cells that are more
than several hundred microns from blood vessels in the
surrounding tissue frequently either fail to engraft or die
rapidly due to oxygen deprivation.22 Therefore, the pres-
ence of VEGF in the constructs might be extremely ben-
eficial for the development of new bone tissue as it is
likely to enhance their vascularization upon implantation
and thus provide adequate delivery of nutrients and oxy-
gen into the developing tissue.
Like VEGF, FGFs are also angiogenic factors that are
important for neovascularization during bone healing.5
FGFs have primarily a proliferative effect on osteoblasts
and a lesser effect on protein synthesis. Consequently,
they probably enhance bone formation by increasing the
number of cells capable of synthesizing bone ma-
trix.5,23,24 FGF-2 can also stimulate the TGF-! synthesis
by osteoblasts and may therefore exert some stimulatory
effects through other growth factors.5,23 Therefore, the
expression of these growth factors in the scaffold/cell
constructs cultured under flow perfusion can have a pos-
itive impact on the functionality of these tissue engi-
neered substitutes upon implantation.
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FIG. 5. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow perfusion
for 10 and 16 days, at two different flow rates and immunostained for TGF-!1. (A) Construct cultured for 10 days at a flow rate
of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/min; (C) Construct cultured for 16 days at a flow rate
of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1 mL/min. (Images available in color in online version.)
The presence of the platelet-derived growth factors
(PDGF), which was not observed in this study, could have
important effects in the early stages of fracture healing, as
it can be released during platelet aggregation.5,6 In addi-
tion to its effect on bone formation (PDGF stimulates DNA
and protein synthesis), PDGF has been shown to stimulate
bone resorption, appearing to have a complex effect on
bone remodeling.6 However, as previously discussed, it is
not possible to conclude if this growth factor is present in
the described system at earlier or later stages of culture,
nor is it possible to predict if the absence of PDGF in the
transplanted construct would somehow compromise the
adaptation of the implanted construct.
TGF-!1, by itself or in conjunction with other growth
regulators, has a major function in bone formation6,25,26
as it influences a broad range of cellular activities, in-
cluding growth, proliferation, differentiation, and extra-
cellular matrix synthesis. It is probably the most potent
multifunctional regulator of bone cell metabolism.5,6
Consequently, its presence on a bone tissue engineering
construct would certainly have a positive effect on the
functionality and adaptation of the implant.
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Bone morphogenetic proteins (BMPs) belong to the
same family as TGF-!1, the TGF-! superfamily, and are
known to induce the differentiation of undifferentiated
mesenchymal cells into chondrogenic and osteogenic
cells and promote their differentiation.5,7 In vivo this ac-
tion may result in bone generation and thus fracture re-
pair by the newly formed bone.27 At the cellular level,
undifferentiated mesenchymal cells proliferate from the
periosteum, bone marrow, and muscle surrounding the
fracture and begin to migrate. As a result, new bone is
produced in conjunction with their differentiation into
chondrogenic and osteogenic cells. In fact, it has been
demonstrated that certain BMPs (BMP-2 and/or BMP-4)
are present at the initial stage of this fracture healing pro-
cess and seem to play an important role in several events
of the bone formation cascade that leads to bone repair.1
Due to its capability of eliciting new bone formation,
BMPs have been widely used in bone tissue engineering
strategies27,28 using a carrier device for delivery at the
implantation site. Although the efficacy of this approach
in enhancing new bone formation has been shown both
orthotopically and heterotopically in several different ex-
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FIG. 6. Light microscopy images (4 " original magnification) of SPCL scaffold/cell constructs cultured under flow perfusion
for 10 and 16 days, at two different flow rates and immunostained for FGF-2. (A) Construct cultured for 10 days at a flow rate
of 0.3 mL/min. (B) Construct cultured for 10 days at a flow rate of 1 mL/min. (C) Construct cultured for 16 days at a flow rate
of 0.3 mL/min. (D) Construct cultured for 16 days at a flow rate of 1 mL/min. (Images available in color in online version.)
perimental animal models,27–32 the inability to find an
ideal delivery system has limited the use of this ap-
proach.27,29,32
The images taken in this in vitro study may not be
compared with those obtained from samples from in vivo
studies.18 In vivo there is formation of new tissue within
a scaffold while in vitro the tissue formation may not be
continuous or sufficient to produce stable sections for im-
munohistochemical analysis. The large number of incu-
bations and washings involved in this analysis may also
compromise the final appearance of a section. Neverthe-
less, this study demonstrates that immunohistochemical
analysis can be used to characterize the quality of extra-
cellular matrix generated in vitro using a flow perfusion
bioreactor.
This study shows that osteoprogenitor cells seeded in
a starch-based biodegradable matrix and stimulated by
flow perfusion culturing may be able to deliver growth
factors, including BMP-2 after implantation, providing
an osteoinductive scaffold for bone regeneration in crit-
ical size defects. In this sense, flow perfusion augments
the functionality of scaffold/cell constructs grown in vitro
as it combines both biological and mechanical factors to
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enhance cell differentiation and cell organization within
the construct.
The results suggest that flow perfusion bioreactor cul-
ture of marrow stromal cells combined with biodegrad-
able starch-based fiber meshes may constitute a useful
model for in vitro research on the biological mechanisms
associated with bone formation and regeneration. The
true biological environment of a bone cell is derived from
a dynamic interaction between responsively active cells
experiencing mechanical forces and a continuously
changing three-dimensional matrix architecture, which
can be simulated to a limited extent, in this type of biore-
actor. Moreover, the data show that starch-based fiber
meshes support the expression of the different growth
factors by rat bone marrow stromal cells cultured within
these scaffolds, providing further evidence of their suit-
ability for bone tissue engineering applications.
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